SRDX
Price
$29.94
Change
-$0.88 (-2.86%)
Updated
Sep 26 closing price
Capitalization
428.07M
38 days until earnings call
TFX
Price
$119.99
Change
+$2.99 (+2.56%)
Updated
Sep 26 closing price
Capitalization
5.3B
25 days until earnings call
Interact to see
Advertisement

SRDX vs TFX

Header iconSRDX vs TFX Comparison
Open Charts SRDX vs TFXBanner chart's image
Surmodics
Price$29.94
Change-$0.88 (-2.86%)
Volume$282.36K
Capitalization428.07M
Teleflex
Price$119.99
Change+$2.99 (+2.56%)
Volume$933.27K
Capitalization5.3B
SRDX vs TFX Comparison Chart in %
Loading...
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SRDX vs. TFX commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRDX is a Hold and TFX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (SRDX: $29.94 vs. TFX: $119.99)
Brand notoriety: SRDX and TFX are both not notable
SRDX represents the Medical/Nursing Services, while TFX is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: SRDX: 113% vs. TFX: 154%
Market capitalization -- SRDX: $428.07M vs. TFX: $5.3B
SRDX [@Medical/Nursing Services] is valued at $428.07M. TFX’s [@Pharmaceuticals: Other] market capitalization is $5.3B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $232.44B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $158.13B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.42B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRDX’s FA Score shows that 0 FA rating(s) are green whileTFX’s FA Score has 1 green FA rating(s).

  • SRDX’s FA Score: 0 green, 5 red.
  • TFX’s FA Score: 1 green, 4 red.
According to our system of comparison, TFX is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRDX’s TA Score shows that 5 TA indicator(s) are bullish while TFX’s TA Score has 5 bullish TA indicator(s).

  • SRDX’s TA Score: 5 bullish, 5 bearish.
  • TFX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TFX is a better buy in the short-term than SRDX.

Price Growth

SRDX (@Medical/Nursing Services) experienced а -7.51% price change this week, while TFX (@Pharmaceuticals: Other) price change was -2.15% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.97%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +8.73%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.13%. For the same industry, the average monthly price growth was -3.06%, and the average quarterly price growth was +8.48%.

Reported Earning Dates

SRDX is expected to report earnings on Nov 05, 2025.

TFX is expected to report earnings on Oct 23, 2025.

Industries' Descriptions

@Medical/Nursing Services (-1.97% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TFX($5.3B) has a higher market cap than SRDX($428M). SRDX has higher P/E ratio than TFX: SRDX (43.13) vs TFX (27.97). SRDX YTD gains are higher at: -24.394 vs. TFX (-32.044). TFX has higher annual earnings (EBITDA): 601M vs. SRDX (-2.74M). TFX has more cash in the bank: 254M vs. SRDX (32.7M). SRDX has less debt than TFX: SRDX (32.6M) vs TFX (2B). TFX has higher revenues than SRDX: TFX (3.04B) vs SRDX (121M).
SRDXTFXSRDX / TFX
Capitalization428M5.3B8%
EBITDA-2.74M601M-0%
Gain YTD-24.394-32.04476%
P/E Ratio43.1327.97154%
Revenue121M3.04B4%
Total Cash32.7M254M13%
Total Debt32.6M2B2%
FUNDAMENTALS RATINGS
SRDX vs TFX: Fundamental Ratings
SRDX
TFX
OUTLOOK RATING
1..100
5875
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
29
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9587
PRICE GROWTH RATING
1..100
6364
P/E GROWTH RATING
1..100
9386
SEASONALITY SCORE
1..100
3985

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TFX's Valuation (29) in the Medical Specialties industry is somewhat better than the same rating for SRDX (94). This means that TFX’s stock grew somewhat faster than SRDX’s over the last 12 months.

TFX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as SRDX (100). This means that TFX’s stock grew similarly to SRDX’s over the last 12 months.

TFX's SMR Rating (87) in the Medical Specialties industry is in the same range as SRDX (95). This means that TFX’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's Price Growth Rating (63) in the Medical Specialties industry is in the same range as TFX (64). This means that SRDX’s stock grew similarly to TFX’s over the last 12 months.

TFX's P/E Growth Rating (86) in the Medical Specialties industry is in the same range as SRDX (93). This means that TFX’s stock grew similarly to SRDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRDXTFX
RSI
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
63%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
Bearish Trend 4 days ago
70%
Bearish Trend 3 days ago
71%
MACD
ODDS (%)
N/A
Bearish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
67%
Bullish Trend 18 days ago
54%
Declines
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 12 days ago
72%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
68%
Bullish Trend 3 days ago
55%
Aroon
ODDS (%)
Bearish Trend 3 days ago
56%
Bullish Trend 3 days ago
45%
View a ticker or compare two or three
Interact to see
Advertisement
SRDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TFX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GCSAX29.100.26
+0.90%
Goldman Sachs Small Cap Eq Insghts A
TMPRX56.270.48
+0.86%
Touchstone Mid Cap R6
SEPCX10.110.06
+0.60%
Saratoga Energy & Basic Materials C
ITGSX79.550.24
+0.30%
VY® T. Rowe Price Growth Equity S
MGFAX9.990.02
+0.20%
MassMutual Global A

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with PXMBF. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then PXMBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-2.86%
PXMBF - SRDX
41%
Loosely correlated
N/A
BDX - SRDX
32%
Poorly correlated
+2.22%
BLCO - SRDX
30%
Poorly correlated
+0.90%
TFX - SRDX
29%
Poorly correlated
+2.56%
UFPT - SRDX
28%
Poorly correlated
+1.84%
More

TFX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TFX has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TFX jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TFX
1D Price
Change %
TFX100%
+2.56%
A - TFX
50%
Loosely correlated
+1.23%
BDX - TFX
49%
Loosely correlated
+2.22%
RVTY - TFX
45%
Loosely correlated
+1.23%
TNDM - TFX
45%
Loosely correlated
+0.33%
SNN - TFX
44%
Loosely correlated
+0.40%
More